Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Quaker Recall Leads to Canada-Wide Class Action


VANCOUVER, BC, Jan. 19, 2024 /CNW/ - Slater Vecchio LLP has filed a class action lawsuit in British Columbia against The Quaker Oats Company and PepsiCo Canada ULC on behalf of all persons in Canada who purchased or claim to have fallen ill from consuming Quaker products that have been recalled due to potential Salmonella contamination.

On January 11, 2024, the Canadian Food Inspection Agency recalled thirty-eight Quaker products, including Quaker-branded granola and cereal products, due to possible Salmonella contamination. The Canadian Food Inspection Agency subsequently recalled over thirty yogurt and parfait products that contained recalled Quaker granola. A full list of the products recalled as of January 16, 2024 is accessible on the Government of Canada's recall database.

Sam Jaworski, a partner at Slater Vecchio LLP, stated, "Canadians trust manufacturers to produce packaged foods that can safely be consumed without the risk of illness from contamination. Through a class action, Canadians can access justice to hold suppliers accountable through strength in numbers, even if it would not be economical to pursue a lawsuit at the individual level."

If you suspect that you have fallen ill after eating a potentially contaminated product, seek medical attention as appropriate. If you have purchased but have not yet consumed a recalled product, follow Health Canada's guidance and either discard the product or return it to the location from where you purchased it.

Slater Vecchio LLP is seeking to identify individuals who fell ill from consuming a recalled product. Please submit your information on our website at https://www.slatervecchio.com/class-action/quaker-granoloa-salmonella-class-action/.

SOURCE Slater Vecchio LLP


These press releases may also interest you

at 08:16
Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by Leads Biolabs with global intellectual property rights has received approval to...

at 08:15
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Ms. Adelina Louie Ngar Yee made an individual purchase of 19,665...

at 08:15
Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced its speaker lineup for presentations at the upcoming Global Synthetic Biology (SynBioBeta) Conference in San Jose, Calif., from May 6-9, 2024. The company is...

at 08:15
Qlaris Bio, Inc. ("Qlaris"), a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced that it has closed a $24 million Series B financing round. Co-led by Canaan and New Leaf Venture Partners,...

at 08:12
DSFederal, Inc., and its strategic alliance partner, Taiwan AI Labs, are excited to announce their participation in the upcoming AI Expo for National Competitiveness scheduled to take place on May 7-8 at the Walter E. Washington Convention Center in...

at 08:10
Desktop Health ? the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. ? and Asiga, a leading dental 3D printing brand, have validated Flexcera Smile Ultra+, Flexcera Smile, and Flexcera Base for use on the Asiga 3D printing...



News published on and distributed by: